1-[4-(DiMethylaMino)phenyl]-3-(2-hydroxy-3,4-diMethoxyphenyl)-1,3-propanedione
![1-[4-(DiMethylaMino)phenyl]-3-(2-hydroxy-3,4-diMethoxyphenyl)-1,3-propanedione price.](/CAS/GIF/1205548-02-2.gif)
|
- $165 - $2200
- Product name: 1-[4-(DiMethylaMino)phenyl]-3-(2-hydroxy-3,4-diMethoxyphenyl)-1,3-propanedione
- CAS: 1205548-02-2
- MF: C19H21NO5
- MW: 343.37
- EINECS:
- MDL Number:MFCD30186725
- Synonyms:1-[4-(DiMethylaMino)phenyl]-3-(2-hydroxy-3,4-diMethoxyphenyl)-1,3-propanedione;1,3-Propanedione, 1-[4-(dimethylamino)phenyl]-3-(2-hydroxy-3,4-dimethoxyphenyl)-
3 prices
Selected condition：
Brand
- Medical Isotopes, Inc.
- TRC
Package
- 50mg
- 500mg
- ManufacturerMedical Isotopes, Inc.
- Product number40011
- Product description1-[4-(Dimethylamino)phenyl]-3-(2-hydroxy-3,4-dimethoxyphenyl)-1,3-propanedione
- Packaging500mg
- Price$2200
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberD461190
- Product description1-[4-(Dimethylamino)phenyl]-3-(2-hydroxy-3,4-dimethoxyphenyl)-1,3-propanedione
- Packaging50mg
- Price$165
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberD461190
- Product description1-[4-(Dimethylamino)phenyl]-3-(2-hydroxy-3,4-dimethoxyphenyl)-1,3-propanedione
- Packaging500mg
- Price$1320
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Medical Isotopes, Inc. | 40011 | 1-[4-(Dimethylamino)phenyl]-3-(2-hydroxy-3,4-dimethoxyphenyl)-1,3-propanedione | 500mg | $2200 | 2021-12-16 | Buy |
| TRC | D461190 | 1-[4-(Dimethylamino)phenyl]-3-(2-hydroxy-3,4-dimethoxyphenyl)-1,3-propanedione | 50mg | $165 | 2021-12-16 | Buy |
| TRC | D461190 | 1-[4-(Dimethylamino)phenyl]-3-(2-hydroxy-3,4-dimethoxyphenyl)-1,3-propanedione | 500mg | $1320 | 2021-12-16 | Buy |
Properties
solubility :Dichloromethane, Methanol
form :Solid
color :Yellow
form :Solid
color :Yellow
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|